Galleri Multi-Cancer Blood Test: FDA Review and Screening Impact
The FDA is reviewing GRAIL’s Premarket Approval application for the Galleri multi-cancer early detection test, which scans a single blood vial for signals from up to 50 cancer types. In … Read More